Neuromelanin or DaT‐<scp>SPECT</scp>: which is the better marker for discriminating advanced Parkinson's disease?

Abstract

NM-SNc size was significantly correlated with the SBR in PD, but several factors in advanced PD were more closely associated with NM-SNc size than the SBR. NM-MRI might reflect the status of advanced PD more accurately than DaT-SPECT. Therefore, NM-MRI appears to provide a better marker for discriminating advanced PD than DaT-SPECT.